Neurology

The FDA has approved a new migraine injection available in weekly and monthly dosing options.

Researchers evaluated the value of neurofilament light chain levels as a cerebrospinal fluid or blood biomarker in patients with MS.

Researchers have discovered a new subtype of MS, providing a better understanding of the nature of the disease.

The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.

New data on nearly 71,000 patients with Alzheimer disease point toward a potential association between Alzheimer risk and the use of commonly prescribed treatments for anxiety, insomnia, and related...

Discontinuing disease-modifying therapies is common among patients with MS but can increase the risk of progression or relapse.

The US Food and Drug Administration has granted approval to the first treatment in a new drug class for a nerve condition that affects about 50,000 people worldwide.

Anxiety is common in persons with Parkinson disease, but little is known about its pathophysiology. Researchers set out to explore the connection.

Researchers compared the characteristics of patients with migraine alone compared with patients with migraines and comorbid noncephalic pain in order to better understand and meet the unique needs of those...

The Alzheimer’s Association has released new information on its first-ever clinical practice guidelines for primary care physicians evaluating Alzheimer disease, dementia, and neurodegenerative cognitive...